Rite Aid Corporation (NYSE:RAD) announced sales results for May. For the five weeks ended May 28, 2011, same store sales increased 1.3 percent over the prior-year period. May front-end same store sales increased 1.8 percent while pharmacy same store sales, which included an approximate 129 basis points negative impact from new generic introductions, increased 1.0 percent. Prescription count at comparable stores increased 0.1 percent over the prior-year period.

Rite Aid Corporation, through its subsidiaries, operates retail drugstores in the United States. The company drugstores primarily offer pharmacy services.

************************************

Crown Equity Holdings Inc. (CRWE)

Crown Equity Holdings Inc., recently announced that it has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.

Online publishing offers several advantages: accessibility, reduced cost (in some instances), and "interactivity, media capability, and dynamic response. Many of the advantages are also disadvantages. Addressing these in reverse order, this journal was established to explore the flexibility of web-based publishing.

Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.

CRWE's digital network is designed, on behalf of its clients, to bring together targeted high-income audiences and advertisers on its financial websites that include, among others, DrStockPick.com, PennyOmega.com, BestOtc.com, CRWEFinance.com, CRWESelect.com, CRWEPicks.com and StockHotTips.com.

For more information, please visit their website: http://www.crownequityholdings.com

************************************

Power3 Medical Products, Inc. (PWRM.OB)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

Power3 Medical Products, Inc. applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical Products, Inc. has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, for which it is currently engaged in Phase II clinical trials.

These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks. In most people with Alzheimer's, symptoms first appear after age 60.

Alzheimer's disease is the most common cause of dementia among older people. Dementia is the loss of cognitive functioning-thinking, remembering, and reasoning-to such an extent that it interferes with a person's daily life and activities. Estimates vary, but experts suggest that as many as 5.1 million Americans may have Alzheimer's.

For more details, please visit the website: http://www.power3medical.com

************************************

Horizon Lines, Inc. (NYSE:HRZ) announced that shareholders at the company's annual meeting today re-elected two Class III directors and ratified the appointment of Horizon Lines' public accounting firm Ernst & Young LLP. During the annual meeting, shareholders re-elected Class III directors Thomas P. Storrs and Bobby J. Griffin. Mr. Storrs has served as a director for the company since June 2007, and Mr. Griffin has served since June 2010.

Horizon Lines, Inc., through its subsidiaries, provides container shipping and integrated logistics services. It ships a range of consumer and industrial items, such as refrigerated and non-refrigerated foodstuffs, household goods, auto parts, building materials, and other materials used in manufacturing.

************************************

The First Marblehead Corporation (NYSE:FMD) announced that Daniel Meyers, Chief Executive Officer, and Kenneth Klipper, Chief Financial Officer, will present at the Keefe, Bruyette & Woods 2011 Investment Management & Specialty Finance Conference in New York, NY on Wednesday, June 8, at 8:00 am (ET). Interested parties can access the live webcast by visiting the Investors page on First Marblehead's website at www.firstmarblehead.com.

The First Marblehead Corporation, together with its subsidiaries, provides outsourcing services for designing and implementing private education loan programs to national and regional financial institutions, and educational institutions in the United States.

******************************************************************

For FREE Daily Stock Alerts & Updates Sign-up At: http://pennytobuck.com/signup

******************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).